Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Cigarette Smoke Exposure on Efferocytosis in Chronic Obstructive Pulmonary Disease; Molecular Mechanisms and Treatment Opportunities Publisher Pubmed



Tajbakhsh A1 ; Gheibihayat SM2 ; Mortazavi D3 ; Medhati P4 ; Rostami B5 ; Savardashtaki A6, 7 ; Momtaziborojeni AA8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  3. 3. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran
  4. 4. Student research committee, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Health & Treatment Center of Rostam, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  7. 7. Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
  8. 8. Department of Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease Published:2021


Abstract

Cigarette smoking-related inflammation, cellular stresses, and tissue destruction play a key role in lung disease, such as chronic obstructive pulmonary disease (COPD). Notably, augmented apoptosis and impaired clearance of apoptotic cells, efferocytosis, contribute to the chronic inflammatory response and tissue destruction in patients with COPD. Of note, exposure to cigarette smoke can impair alveolar macrophages efferocytosis activity, which leads to secondary necrosis formation and tissue inflammation. A better understanding of the processes behind the effect of cigarette smoke on efferocytosis concerning lung disorders can help to design more efficient treatment approaches and also delay the development of lung disease, such as COPD. To this end, we aimed to seek mechanisms underlying the impairing effect of cigarette smoke on macrophages-mediated efferocytosis in COPD. Further, available therapeutic opportunities for restoring efferocytosis activity and ameliorating respiratory tract inflammation in smokers with COPD were also discussed. © 2021 Taylor & Francis Group, LLC.